Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
Pharmacopsychiatry|February 1, 1987
Zotepine in the treatment of negative symptoms in chronic schizophreniaW W Fleischhacker, C Barnas, C Stuppäck, et al.Pharmacopsychiatry|February 1, 1987
Results of an open phase II study with zotepine--a new neuroleptic compoundW W Fleischhacker, B Unterweger, C Barnas, et al.Journal of Clinical Psychopharmacology|February 1, 1990
Carbamazepine in the prophylaxis of mood disordersC Stuppaeck, C Barnas, C Miller, et al.Acta Medica Austriaca|May 31, 2001
[Prescription patterns and quality of information provided for consumers of benzodiazepines]K Gutiérrez-Lobos, S Fröhlich, S Quiner, et al.The Journal of Clinical Psychiatry|October 1, 1994
Clozapine-induced transient white blood count disordersM Hummer, M Kurz, C Barnas, et al.The Journal of Infectious Diseases|August 10, 2006
Antagonism between the HIV-1 reverse-transcriptase mutation K65R and thymidine-analogue mutations at the genomic levelUrvi M Parikh, Douglas C Barnas, Hawazin Faruki, et al.Journal of Clinical Psychopharmacology|December 1, 1992
Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preferenceC Barnas, M Rossmann, H Roessler, et al.Pharmacopsychiatry|February 1, 1987
Low-dose zotepine in the maintenance treatment of schizophreniaW W Fleischhacker, C Stuppäck, C Barnas, et al.International Clinical Psychopharmacology|July 1, 1986
Piracetam in alcoholic organic mental disorder: a placebo controlled study comparing two dosagesW W Fleischhacker, V Günther, C Barnas, et al.European Archives of Psychiatry and Clinical Neuroscience|February 2, 2000
Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophreniaS Kasper, J Tauscher, B Küfferle, et al.Pageof 6